Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 28:10:417.
doi: 10.3389/fendo.2019.00417. eCollection 2019.

The Warburg Effect Is Associated With Tumor Aggressiveness in Testicular Germ Cell Tumors

Affiliations

The Warburg Effect Is Associated With Tumor Aggressiveness in Testicular Germ Cell Tumors

Murilo Bonatelli et al. Front Endocrinol (Lausanne). .

Abstract

Testicular Germ Cell Tumors (TGCTs) are a rare group of neoplasms and the most common solid malignancy arising in young male adults. Despite the good response of these tumors to platinum-based chemotherapy, some patients are refractory to treatment and present poor clinical outcomes. During carcinogenesis and tumor development, cancer cells reprogram energy metabolism toward a hyper-glycolytic phenotype, an emerging hallmark of cancer. This phenomenon, known as the Warburg effect or aerobic glycolysis, involves overexpression of metabolism-related proteins, like glucose and monocarboxylate transporters, pH regulators and intracellular glycolytic enzymes. The metabolic profile of TGCTs is very little explored and, recently, this metabolic rewiring of cancer cells has been associated with aggressive clinicopathological characteristics of these tumors. The overexpression of monocarboxylate transporter 4 (MCT4) in TGCTs has been pointed out as a poor prognostic factor, as well as a promising therapeutic target. As a result, the main aim of the present study was to evaluate the prognostic value of key metabolism-related proteins in TGCTs. The immunohistochemical expressions of CD44 (as a monocarboxylate transporter chaperone), glucose transporter 1 (GLUT1), carbonic anhydrase IX (CAIX), hexokinase II (HKII) and lactate dehydrogenase V (LDHV) were evaluated in a series of 148 adult male patients with TGCTs and associated with clinicopathological parameters. In addition, paired normal tissues were also evaluated. The sample included 75 seminoma and 73 non-seminoma tumors. GLUT1 and CD44 expression was significantly increased in malignant samples when compared to paired normal samples. Conversely, HKII and LDHV expressions were significantly decreased in malignant samples. Concerning the clinicopathological values, CAIX expression was significantly associated with disease recurrence, while HKII expression was significantly associated with aggressive characteristics of TGCTs, including higher staging and non-seminoma histology. In conclusion, this study brings new insights on the metabolic characteristics of TGCTs, showing alterations in the expression of proteins related with the Warburg effect, as well as associations of the hyper-glycolytic and acid-resistant phenotype with aggressive clinicopathological parameters.

Keywords: Warburg effect; immunohistochemistry; metabolic reprogramming; testicular germ cell tumors; testicular neoplasms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunohistochemical expression of CD44 (A), GLUT1 (B), CAIX (C), HKII (D), and LDHV (E) in adult testicular germ cell tumors. CD44, GLUT1, and CAIX show plasma membrane staining, while HKII and LDHV show cytoplasmic staining. Magnification: 400x.
Figure 2
Figure 2
Plasma membrane expression of GLUT1, CAIX, and CD44 and cytoplasmic expression of HKII and LDHV in adult testicular germ cell tumors and correspondent normal testicular tissues. McNemar's test was used to assess differences of expression frequency between tumor and normal tissue. *p = 0.004, **p < 0.001.

References

    1. Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C. Testicular germ cell tumours. Lancet. (2016) 387:1762–74. 10.1016/S0140-6736(15)00991-5 - DOI - PubMed
    1. Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. (2018) 23:3392–406. 10.1016/j.celrep.2018.05.039 - DOI - PMC - PubMed
    1. Horwich A, Nicol D, Huddart R. Testicular germ cell tumours. BMJ. (2013) 347:f5526. 10.1136/bmj.f5526 - DOI - PubMed
    1. Litchfield K, Levy M, Huddart RA, Shipley J, Turnbull C. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment. Nat Rev Urol. (2016) 13:409–19. 10.1038/nrurol.2016.107 - DOI - PubMed
    1. Hanna N, Einhorn LH. Testicular cancer: a reflection on 50 years of discovery. J Clin Oncol. (2014) 32:3085–92. 10.1200/JCO.2014.56.0896 - DOI - PubMed